70 related articles for article (PubMed ID: 17721276)
1. Comparison of the Dako EGFR pharmDx kit and Zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma.
Buckley AF; Kakar S
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):305-9. PubMed ID: 17721276
[TBL] [Abstract][Full Text] [Related]
2. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
[TBL] [Abstract][Full Text] [Related]
4. Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
Penault-Llorca F; Cayre A; Arnould L; Bibeau F; Bralet MP; Rochaix P; Savary J; Sabourin JC
Oncol Rep; 2006 Dec; 16(6):1173-9. PubMed ID: 17089034
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Hirsch FR; Dziadziuszko R; Thatcher N; Mann H; Watkins C; Parums DV; Speake G; Holloway B; Bunn PA; Franklin WA
Cancer; 2008 Mar; 112(5):1114-21. PubMed ID: 18219661
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer.
Mathieu A; Weynand B; Verbeken E; Da Silva S; Decaestecker C; Salmon I; Demetter P
Lung Cancer; 2010 Jul; 69(1):46-50. PubMed ID: 19796839
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
8. Implications of EGFR PharmDx kit for cetuximab eligibility.
Ensinger C; Sterlacci W
Expert Rev Mol Diagn; 2008 Mar; 8(2):141-8. PubMed ID: 18366301
[TBL] [Abstract][Full Text] [Related]
9. Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry.
Seo AN; Park TI; Jin Y; Sun PL; Kim H; Chang H; Chung JH
Lung Cancer; 2014 Mar; 83(3):316-23. PubMed ID: 24412618
[TBL] [Abstract][Full Text] [Related]
10. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies.
Buffet W; Geboes KP; Dehertogh G; Geboes K
Acta Gastroenterol Belg; 2008; 71(2):213-8. PubMed ID: 18720932
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Scartozzi M; Bearzi I; Mandolesi A; Galizia E; Pierantoni C; Loupakis F; Berardi R; Zaniboni A; Quadri A; Zorzi F; Biagetti S; Loretelli C; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
Anal Quant Cytol Histol; 2009 Dec; 31(6):417-23. PubMed ID: 20698358
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor analyses in colorectal cancer: a comparison of methods.
Spindler KL; Lindebjerg J; Nielsen JN; Olsen DA; Bisgård C; Brandslund I; Jakobsen A
Int J Oncol; 2006 Nov; 29(5):1159-65. PubMed ID: 17016647
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity epidermal growth factor receptor immunostaining for colorectal carcinomas, compared with EGFR PharmDx™: a study of diagnostic accuracy.
Shiogama K; Wongsiri T; Mizutani Y; Inada K; Tsutsumi Y
Int J Clin Exp Pathol; 2013; 6(1):24-30. PubMed ID: 23236539
[TBL] [Abstract][Full Text] [Related]
15. EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients.
Li YH; Wang F; Shen L; Deng YM; Shao Q; Feng F; An X; Wang FH; Wang ZQ; Xu RH; Shao JY
Clin Cancer Res; 2011 Jan; 17(2):382-90. PubMed ID: 20884623
[TBL] [Abstract][Full Text] [Related]
16. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray.
Bibeau F; Boissière-Michot F; Sabourin JC; Gourgou-Bourgade S; Radal M; Penault-Llorca F; Rochaix P; Arnould L; Bralet MP; Azria D; Ychou M
Virchows Arch; 2006 Sep; 449(3):281-7. PubMed ID: 16865406
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor Inconsistency by Immunohistochemistry Method Using Different Monoclonal Antibodies in Colorectal Cancer Patients.
Fan CC; Wang TY; Kung CM
Clin Lab; 2015; 61(11):1635-41. PubMed ID: 26731987
[TBL] [Abstract][Full Text] [Related]
18. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease.
Khalifa MA; Rowsell CH; Gladdy RA; Ko YJ; Hanna S; Smith A; Law C
Am J Clin Pathol; 2006 Feb; 125(2):229-33. PubMed ID: 16393679
[TBL] [Abstract][Full Text] [Related]
20. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
